MedKoo Cat#: 462443 | Name: PKR-IN-2
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PKR-IN-2 is a pyruvate kinase (PKR) activator.

Chemical Structure

PKR-IN-2
PKR-IN-2
CAS#1628428-01-2

Theoretical Analysis

MedKoo Cat#: 462443

Name: PKR-IN-2

CAS#: 1628428-01-2

Chemical Formula: C24H28N4O4S

Exact Mass: 468.1831

Molecular Weight: 468.57

Elemental Analysis: C, 61.52; H, 6.02; N, 11.96; O, 13.66; S, 6.84

Price and Availability

Size Price Availability Quantity
5mg USD 700.00 2 Weeks
10mg USD 1,200.00 2 Weeks
50mg USD 2,450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
PKR-IN-2; PKR IN 2; PKR IN-2; PKR-IN 2
IUPAC/Chemical Name
N-(4-(4-hydroxy-4-isobutylpiperidine-1-carbonyl)phenyl)quinoxaline-5-sulfonamide
InChi Key
JTGUGSWLWPKCGF-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H28N4O4S/c1-17(2)16-24(30)10-14-28(15-11-24)23(29)18-6-8-19(9-7-18)27-33(31,32)21-5-3-4-20-22(21)26-13-12-25-20/h3-9,12-13,17,27,30H,10-11,14-16H2,1-2H3
SMILES Code
O=C(N1CCC(CC(C)C)(O)CC1)C2=CC=C(NS(C3=C(N=CC=N4)C4=CC=C3)(=O)=O)C=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
PKR activator 3 is a pyruvate kinase isoform PKR activator.
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM comments
Solubility
DMSO 72.0 153.66
Ethanol 1.0 2.13
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 468.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Popovici-Muller, et al. Preparation of N-(piperidinecarbonylphenyl) sulfonamide compounds as pyruvate kinase modulators. From PCT Int. Appl. (2014), WO2014139144A1 20140918. 2: Cianchetta Giovanni, et al. Preparation of aroylpiperidines, particularly arysulfonylamino and heteroarylsulfonylamino substituted, as pyruvate kinase PKM2 modulators useful in the treatment of cancer and compositions containing them. From PCT Int. Appl. 3: Shogren, K. L., Turner, R. T., Yaszemski, M. J., & Maran, A. (2007). Double‐Stranded RNA‐Dependent Protein Kinase Is Involved in 2‐Methoxyestradiol—Mediated Cell Death of Osteosarcoma Cells. Journal of Bone and Mineral Research, 22(1), 29-36. 4: Kim, S., Lee, K., Choi, Y. S., Ku, J., Lee, Y. J., & Kim, Y. (2020). Mitochondrial dsRNAs activate PKR and TLR3 to promote chondrocyte degeneration in osteoarthritis. BioRxiv, 2020-06. 5: CAPLAN, E., Sheer, R., Schmedt, N., Evers, T., Cockrell, M., Tindall, M., ... & Kovesdy, C. P. (2021). POS-344 ASSOCIATION BETWEEN RELATIVE ESTIMATED GLOMERULAR FILTRATION RATE CHANGES AND CLINICAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES. Kidney International Reports, 6(4), S149. 6: Spector, M., Pepinsky, R. B., Vogt, V. M., & Racker, E. (1981). A mouse homolog to the avian sarcoma virus src protein is a member of a protein kinase cascade. Cell, 25(1), 9-21.